(2S,5S)-5-hydroxypiperidine-2-carboxylic acid hydrochloride

(2S,5S)-5-hydroxypiperidine-2-carboxylic acid hydrochloride Suppliers list
Company Name: Chengdu Firster Pharmaceutical Co., Ltd.  
Tel: 028-87078428 028-87074958
Email: chengzhenyong@cdfirster.com
Company Name: JW & Y Pharmlab Co., Ltd.  
Tel: 021-64340559
Email: xinyu_shi@jwypharmlab.com.cn
Company Name: ChengDu TongChuangYuan Pharmaceutical Co.Ltd  
Tel: 028-83379370 13880556291
Email: tcy@tcypharm.com
Company Name: Jinan elephant international trading co., LTD  
Tel:
Email: 13006575422@163.com
Company Name: Amadis Chemical Company Limited  
Tel: 571-89925085
Email: sales@amadischem.com
(2S,5S)-5-hydroxypiperidine-2-carboxylic acid hydrochloride Basic information
Product Name:(2S,5S)-5-hydroxypiperidine-2-carboxylic acid hydrochloride
Synonyms:(2S,5S)-5-hydroxypiperidine-2-carboxylic acid hydrochloride;EOS-62364;2-Piperidinecarboxylic acid, 5-hydroxy-, hydrochloride (1:1), (2S,5S)-;(2S,5S)-5-hydroxypiperidine-2-carboxylic acid hydrogen chloride
CAS:154307-84-3
MF:C6H12ClNO3
MW:181.62
EINECS:
Product Categories:
Mol File:154307-84-3.mol
(2S,5S)-5-hydroxypiperidine-2-carboxylic acid hydrochloride Structure
(2S,5S)-5-hydroxypiperidine-2-carboxylic acid hydrochloride Chemical Properties
storage temp. Inert atmosphere,Room Temperature
AppearanceWhite to off-white Solid
Safety Information
MSDS Information
(2S,5S)-5-hydroxypiperidine-2-carboxylic acid hydrochloride Usage And Synthesis
Synthesis
(2S,5S)-tert-butyl 5-hydroxypiperidine-2-carboxylate(2S,5S)-tert-butyl 5-hydroxypiperidine-2-carboxylate

1383814-52-5

(2S,5S)-5-hydroxypiperidine-2-carboxylic acid hydrochloride

154307-84-3

The general procedure for the synthesis of (2S,5S)-5-hydroxypiperidine-2-carboxylic acid hydrochloride from the compound (CAS:1383814-52-5) is as follows: Step 1: Preparation of (2S,5S)-5-hydroxypiperidine-2-carboxylic acid hydrochloride (2S,5S)-5-hydroxypiperidine-2-carboxylic acid tert-butyl ester (126.22 g, 0.63 mol) was gradually added to 5 M hydrochloric acid (630 mL) at room temperature, followed by heating to 65 °C and stirring for 2 hours. Upon completion of the reaction, the reaction solution was cooled to room temperature and the solvent was removed by concentration under reduced pressure. The residue was dissolved in water (500 mL), activated carbon (6.5 g) was added and stirred at room temperature for 30 minutes. The activated carbon was removed by diatomaceous earth filtration and the diatomaceous earth was washed twice with (100 mL) water, the filtrates were combined and concentrated under reduced pressure. The resulting residue (150 g) was cooled in an ice bath, inoculated and stirred. Acetone (650 mL) was added slowly and dropwise over 30 minutes and stirring was continued for 30 minutes. The precipitated crystals were filtered under argon protection and washed with acetone. The crystals were dried under vacuum overnight to give 108.79 g of (2S,5S)-5-hydroxypiperidine-2-carboxylic acid hydrochloride as colorless powdery crystals (96% yield). 1H NMR (400 MHz, D2O) δ 1.66-2.23 (m, 4H), 3.25 (d, J = 3.4 Hz, 1H), 3.38 (d, J = 3.4 Hz, 1H), 4.00 (dd, J = 11.7, 3.7 Hz, 1H), 4.22 (brs, 1H); MS m/z: 146 (M-HCl + H)+.

References[1] Patent: EP2857401, 2015, A1. Location in patent: Paragraph 0646
Tag:(2S,5S)-5-hydroxypiperidine-2-carboxylic acid hydrochloride(154307-84-3) Related Product Information
(2S,5S)-5-Hydroxy-2-piperidinecarboxylic acid 2-Piperidinecarboxylic acid, 5-hydroxy-, hydrochloride, (2R-trans)- (2S,5R)-5-Hydroxypipecolic acid HCl 1,2-Piperidinedicarboxylic acid, 5-hydroxy-, 1-(1,1-diMethylethyl) ester, (2S,5S)- 2-Piperidinecarboxylicacid,5-hydroxy-,hydrochloride 2-Piperidinecarboxylic acid, 5-hydroxy-, hydrochloride, (2R-cis)-